Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "Dasatinib Spirig HC 70 mg" (42)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Dasatinib (L01EA02) 42 products
WHO-DDD
L
IP
CI
Dasatinib Spirig HC 20 mg
60
484.40
543.25
10 %
Coated tablets: Dasatinibum 20 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
Dasatinib Spirig HC 50 mg
60
1072.75
1183.10
10 %
Coated tablets: Dasatinibum 50 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
Dasatinib Spirig HC 70 mg
60
1072.75
1183.10
10 %
Coated tablets: Dasatinibum 70 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
Dasatinib Spirig HC 100 mg
30
1102.52
1215.45
10 %
Coated tablets: Dasatinibum 100 mg
Spirig HealthCare AG
A / SL / SG
FB
G
Dasatinib Accord 20 mg
60
PR
PR
k.A.
Coated tablets: Dasatinibum 20 mg
Accord Healthcare AG
A
FB
G
Dasatinib Accord 50 mg
60
PR
PR
k.A.
Coated tablets: Dasatinibum 50 mg
Accord Healthcare AG
A
FB
G
Dasatinib Accord 70 mg
60
PR
PR
k.A.
Coated tablets: Dasatinibum 70 mg
Accord Healthcare AG
A
FB
G
Dasatinib Accord 80 mg
30
PR
PR
k.A.
Coated tablets: Dasatinibum 80 mg
Accord Healthcare AG
A
FB
G
Dasatinib Accord 100 mg
30
PR
PR
k.A.
Coated tablets: Dasatinibum 100 mg
Accord Healthcare AG
A
FB
G
Dasatinib Accord 140 mg
30
PR
PR
k.A.
Coated tablets: Dasatinibum 140 mg
Accord Healthcare AG
A
FB
G
L
SIP
IP
CI
Sprycel 20 mg
60 Tablet(s)
968.80
1040.20
20 %
Coated tablets: Dasatinibum 20 mg
Bristol-Myers Squibb SA
A / SL / SO
FB
G
L
SIP
IP
CI
Sprycel 50 mg
60 Tablet(s)
2145.50
2283.75
20 %
Coated tablets: Dasatinibum 50 mg
Bristol-Myers Squibb SA
A / SL / SO
FB
G
L
SIP
IP
CI
Sprycel 70 mg
60 Tablet(s)
2145.50
2283.75
20 %
Coated tablets: Dasatinibum 70 mg
Bristol-Myers Squibb SA
A / SL / SO
FB
G
L
SIP
IP
CI
Sprycel 100 mg
30 Tablet(s)
2205.04
2346.65
20 %
Coated tablets: Dasatinibum 100 mg
Bristol-Myers Squibb SA
A / SL / SO
FB
G
L
IP
CI
Dasatinib Sandoz 20 mg
60
484.40
543.25
10 %
Coated tablets: Dasatinibum 20 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
Dasatinib Sandoz 50 mg
60
1072.75
1183.10
10 %
Coated tablets: Dasatinibum 50 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
Dasatinib Sandoz 70 mg
60
1072.75
1183.10
10 %
Coated tablets: Dasatinibum 70 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
Dasatinib Sandoz 100 mg
30
1102.52
1215.45
10 %
Coated tablets: Dasatinibum 100 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
CI
Dasatinib Zentiva 20 mg
60
484.40
543.25
10 %
Coated tablets: Dasatinibum 20 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
Dasatinib Zentiva 50 mg
60
1072.75
1183.10
10 %
Coated tablets: Dasatinibum 50 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
Dasatinib Zentiva 70 mg
60
1072.75
1183.10
10 %
Coated tablets: Dasatinibum 70 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
Dasatinib Zentiva 100 mg
30
1102.52
1215.45
10 %
Coated tablets: Dasatinibum 100 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
CI
Dasatinib-Teva 20 mg
60
484.40
543.25
10 %
Coated tablets: Dasatinibum 20 mg
Teva Pharma AG
A / SL / SG
FB
G
L
IP
Dasatinib-Teva 50 mg
60
1072.75
1183.10
10 %
Coated tablets: Dasatinibum 50 mg
Teva Pharma AG
A / SL / SG
FB
G
L
IP
Dasatinib-Teva 70 mg
60
1072.75
1183.10
10 %
Coated tablets: Dasatinibum 70 mg
Teva Pharma AG
A / SL / SG
FB
G
L
IP
Dasatinib-Teva 100 mg
30
1102.52
1215.45
10 %
Coated tablets: Dasatinibum 100 mg
Teva Pharma AG
A / SL / SG
FB
G
IP
Dasatinib Sandoz 80 mg
30
PR
PR
k.A.
Coated tablets: Dasatinibum 80 mg
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Dasatinib Sandoz 140 mg
30
PR
PR
k.A.
Coated tablets: Dasatinibum 140 mg
Sandoz
Pharmaceuticals AG
A
FB
G
IP
CI
Dasatinib-Teva 20 mg
60
PR
PR
k.A.
Coated tablets: Dasatinibum 20 mg
Teva Pharma AG
A
FB
G
IP
Dasatinib-Teva 50 mg
60
PR
PR
k.A.
Coated tablets: Dasatinibum 50 mg
Teva Pharma AG
A
FB
G
IP
Dasatinib-Teva 70 mg
60
PR
PR
k.A.
Coated tablets: Dasatinibum 70 mg
Teva Pharma AG
A
FB
G
IP
Dasatinib-Teva 80 mg
30
PR
PR
k.A.
Coated tablets: Dasatinibum 80 mg
Teva Pharma AG
A
FB
G
IP
Dasatinib-Teva 80 mg
30
PR
PR
k.A.
Coated tablets: Dasatinibum 80 mg
Teva Pharma AG
A
FB
G
IP
Dasatinib-Teva 100 mg
30
PR
PR
k.A.
Coated tablets: Dasatinibum 100 mg
Teva Pharma AG
A
FB
G
SIP
IP
CI
Sprycel 20 mg
60 Tablet(s)
PR
PR
k.A.
Coated tablets: Dasatinibum 20 mg
Bristol-Myers Squibb SA
A
FB
G
SIP
IP
CI
Sprycel 50 mg
60 Tablet(s)
PR
PR
k.A.
Coated tablets: Dasatinibum 50 mg
Bristol-Myers Squibb SA
A
FB
G
SIP
IP
CI
Sprycel 70 mg
60 Tablet(s)
PR
PR
k.A.
Coated tablets: Dasatinibum 70 mg
Bristol-Myers Squibb SA
A
FB
G
SIP
IP
CI
Sprycel 80 mg
30 Tablet(s)
PR
PR
k.A.
Coated tablets: Dasatinibum 80 mg
Bristol-Myers Squibb SA
A
FB
G
SIP
IP
CI
Sprycel 80 mg
30 Tablet(s)
PR
PR
k.A.
Coated tablets: Dasatinibum 80 mg
Bristol-Myers Squibb SA
A
FB
G
SIP
IP
CI
Sprycel 100 mg
30 Tablet(s)
PR
PR
k.A.
Coated tablets: Dasatinibum 100 mg
Bristol-Myers Squibb SA
A
FB
G
SIP
IP
CI
Sprycel 140 mg
30 Tablet(s)
PR
PR
k.A.
Coated tablets: Dasatinibum 140 mg
Bristol-Myers Squibb SA
A
FB
G
SIP
IP
CI
Sprycel 140 mg
30 Tablet(s)
PR
PR
k.A.
Coated tablets: Dasatinibum 140 mg
Bristol-Myers Squibb SA
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home